Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-094-6 | CAS number: 7786-30-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No information on analytical verification
Data source
Reference
- Reference Type:
- publication
- Title:
- Teratogenicity Study of Magnesium Chloride Hexahydrate in Rats
- Author:
- Usami M., Sakemi K., Tsuda M. and Ohno Y.
- Year:
- 1 996
- Bibliographic source:
- Bull. Natl. Inst. Health Sci., 114, 16-20
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- magnesium chloride hexahydrate
- IUPAC Name:
- magnesium chloride hexahydrate
- Reference substance name:
- 7791-18-6
- Cas Number:
- 7791-18-6
- IUPAC Name:
- 7791-18-6
- Details on test material:
- MgCl2·6H2O, Food Additive Quality Magnesium Chloride S, ex Tomita Pharmaceutical Co., Ltd.
A minimum purity of 95%.
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- Wistar rats obtained from Nippon Charles River, Kanagawa, Japan were used.
The nulliparous female and male animals were 10 and 11 weeks old, respectively.
Pregnant animals were kept individually in aluminum cages.
The animals were maintained under controlled environmental conditions of 25 °C ± 2 °C temperature, 55 ± 5% relative humidity, and 12-hours light-dark cycle, (light phase: 6:00 ~ 18:00) and received solid food and tap water ad libitum.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- The concentration of the test substance solution was set at 5 mL/kg/day at each dosage level.
- Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No data
- Details on mating procedure:
- Nulliparous females were mated overnight with males. Females revealing spermatozoa in the vaginal smear in the following morning were considered to be pregnant and used in the experiment. The day, when sperms were found in the vaginal smear, was designated as day 0 of gestation.
- Duration of treatment / exposure:
- From day 6 through 15 of pregnancy (10 days)
- Frequency of treatment:
- By gavage (one by day)
- Duration of test:
- 20 day of gestation
- No. of animals per sex per dose:
- 22
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- The pregnant rats were sacrificed on day 20 of pregnancy and their fetuses were examined for malformation.
For the control group, 5 mL/kg/day distilled water was administered to the animals in the same manner as for the dose groups.
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATION: YES
The general condition of the animals was observed every day.
BODYWEIGHT: Yes
Body weight was measured at day 0, 1, 3, 6, 9, 12, 15, and 17 of pregnancy.
FOOD INTAKE: YES
Food intake was measured at day 0, 1, 3, 6, 9, 12, 15, and 17 of pregnancy. - Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes - Fetal examinations:
- - Weight : Yes all per litter
- External examinations: Yes all per litter
- Soft tissue examinations: Yes all per litter according to a gross sectioning technique (abdominal cavity) and a microdissection technique (thoracic space)
- Skeletal examinations: Yes half per litter (prepared for staining with alizarin red)
- Head examinations: Yes half per litter (according to a gross sectioning technique) - Statistics:
- Pregnant animals or one uterus were taken as sample units. For frequency data, Fisher's direct exact probability test was applied to test the significance of differences between the control group and the magnesium chloride hexahydrate groups. With regard to observation data, statistical analysis and Scheffé's method were applied when no variance differences between the groups were found according to Bartlett's equal variance test. For measured data and count data with variance differences between the groups, we used the H test (Kruskal-Wallis test) and Scheffé's method.
- Indices:
- No data
- Historical control data:
- No data
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:not examined
Details on maternal toxic effects:
There were no differences between the groups with regard to general condition and death. Furthermore, no significant differences between the control group and magnesium chloride hexahydrate groups were observed with respect to body weight and food consumption.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- > 800 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effects
Details on embryotoxic / teratogenic effects:
Regarding the number of corpora lutea, number of implants, number of living fetuses, sex ratio, fetal weight and mortality of implants/fetuses, no significant differences between control group and the magnesium chloride hexahydrate groups were observed.
One to 4 fetuses with gross malformations were found in each group. However, regarding the incidence rate, there was no significant difference between control group and magnesium chloride hexahydrate groups.
In the 800 mg/kg/day group, one fetus had skeleton malformations, however, with regard to the incidence rate; there was no significant difference between control group and the magnesium chloride hexahydrate groups. Furthermore, no significant differences between control group and magnesium chloride hexahydrate groups were observed as far as the incidence rate of skeletal variations is concerned. Regarding the incidence rate of fetuses with lumbar rib and additional rib bones, there were no significant differences. No significant differences were found in the number of ossification centers, metacarpal and metatarsal bones as well as sacral and tail vertebrae. The aforementioned numbers were examined as indicators for the progress of ossification.
Four to 6 fetuses in each group showed malformations, however, no significant difference were observed between control group and magnesium chloride hexahydrate groups.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- > 800 mg/kg bw/day
- Based on:
- test mat.
- Basis for effect level:
- other: teratogenicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Fetal growth in pregnant rats treated with MgCl2, 6H2O
|
Dose (mg/kg/day) |
|||
|
Control |
200 |
400 |
800 |
Nb of litters |
22 |
22 |
22 |
22 |
Nb of corpera lutea |
373 |
370 |
361 |
362 |
Mean +/- SD |
17.0 +/-1.6 |
16.8 +/-2.2 |
16.4 +/-2.1 |
16.5 +/-1.5 |
Nb of implants |
364 |
340 |
345 |
345 |
Mean +/- SD |
16.5 +/-1.7 |
15.5 +/-3.2 |
15.7 +/-1.9 |
15.7 +/-1.8 |
Implantation rate (%) |
97.7 +/-4.5 |
91.4 +/-12.2 |
95.9 +/-6.6 |
95.4 +/-8.3 |
Nb of live fetuses |
346 |
326 |
324 |
332 |
Mean +/- SD |
15.7 +/-1.5 |
14.8 +/-3.5 |
14.7 +/-1.8 |
15.1 +/-1.8 |
Sex ratio male/female |
1.28 |
1.15 |
1.23 |
1.38 |
Fetal weight (g) |
|
|
|
|
Male |
3.95 +/-0.22 |
3.98 +/-0.29 |
3.87+/-0.21 |
3.98 +/-0.22 |
Female |
3.73 +/-0.25 |
3.75 +/-0.23 |
3.72 +/-0.20 |
3.81 +/-0.17 |
Nb of dead implants |
18 |
14 |
21 |
13 |
Early death |
18 |
14 |
21 |
13 |
Late death |
0 |
0 |
0 |
0 |
Mortality (%) |
4.8 +/-4.6 |
4.8 +/-5.8 |
5.9 +/-6.1 |
3.6 +/-5.7 |
Mean +/- SD is shown
Gross malformation in the fetuses from pregnant rats treated with MgCl2, 6H2O
|
Dose (mg/kg/day) |
|||
|
Control |
200 |
400 |
800 |
Nb of litters |
22 |
22 |
22 |
22 |
Nb of fetuses examined |
346 |
326 |
324 |
332 |
Nb of litters with malformed fetuses |
3 |
1 |
3 |
1 |
Nb of fetuses with malformation |
3 |
1 |
4 |
1 |
Skeletal variations the fetuses from pregnant rats treated with MgCl2, 6H2O
|
Dose (mg/kg/day) |
|||
|
Control |
200 |
400 |
800 |
Nb of litters |
22 |
22 |
22 |
22 |
Nb of fetuses examined |
174 |
168 |
165 |
165 |
Nb of fetuses with malformation |
0 |
0 |
0 |
1 |
Nb of fetuses with variation |
76 |
71 |
89 |
84 |
Lumbar rib | 14 | 13 | 18 | 16 |
Visceral variations the fetuses from pregnant rats treated with MgCl2, 6H2O
|
Dose (mg/kg/day) |
|||
|
Control |
200 |
400 |
800 |
Nb of litters |
22 |
22 |
22 |
22 |
Nb of fetuses examined |
170 |
157 |
159 |
166 |
Nb of litters with malformed fetuses |
4 |
4 |
5 |
4 |
Nb of fetuses with malformation |
5 |
4 |
6 |
5 |
Applicant's summary and conclusion
- Conclusions:
- under the condition of this study, It is obvious that magnesium chloride hexahydrate has no teratogenic effect when administered orally to rats from day 6 through 5 of pregancy at dose 800 mg/kg/day.
- Executive summary:
Teratogenicity of magnesium chloride hexahydrate (MgCl2·6 H2O) was examined in rats. Magnesium chloride hexahydrate dissolved in distilled water was given to pregnant Wistar rats by gavage once a day from day 6 through 15 of pregnancy at doses of 0, 200, 400 and 800 mg/kg/day. The pregnant rats were sacrificed on day 20 of pregnancy and their fetuses were examined for malformation. Magnesium chloride hexahydrate caused no increased incidences of fetal malformation, and no toxic signs in the pregnant rats and the fetuses.
It was concluded that magnesium chloride hexahydrate has not teratogenicity in rats when given by gavage. The no observed adverse effect level was estimated to be over 800 mg/kg/day for both pregnant rats and rat fetuses.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.